We propose screening all patients without pathogenic variants in the COL1A1 and COL1A2 genes for the presence of pathogenic variants in the IFITM5 gene, even if they do not have the typical clinical symptoms of OI type V. The gene discussed is IFITM5; the disease is osteogenesis imperfecta type 5.